← Open Payments lookup

RANELL EARL: Open Payments

NPI 1407683113 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$71 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $71

Food & beverage: $71
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Otsuka America Pharmaceutical, Inc.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: AIRSUPRA, XIFAXAN, REXULTI, CAPLYTA.

Industry payments across TX — which companies pay providers there.